SCHEMBL2870649

SCHEMBL2870649

CCCC(CC)C[C]=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9260308 0.88
SCHEMBL78111 0.85 ALDH1A1 (0.50)
SCHEMBL444298 0.83 ALDH1A1 (0.43)
SCHEMBL269288 0.83
SCHEMBL8459302 0.81 LMNA (0.46)
SCHEMBL9262114 0.81 LMNA (0.46)
SCHEMBL7794503 0.80
SCHEMBL5274110 0.78 LMNA (0.43)
SCHEMBL9142070 0.77 ALDH1A1 (0.36)
SCHEMBL9263682 0.77 LMNA (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5352689-A Rhizoxin derivatives and their use as anti-tumor agents SANKYO COMPANY, LIMITED (JP) 1994-10-04 US claimed
CN-112566675-A Freshening compositions comprising controlled release modulators 阿里莱森斯有限公司 2021-03-26 CN disclosed
WO-2020194531-A1 AGENT FOR REDUCING BLOOD UREMIC SUBSTANCE 国立大学法人東北大学 2020-10-01 WO disclosed
US-20170312200-A1 AN AGENT FOR IMPROVING MITOCHONDRIAL FUNCTION SHOWA DENKO K.K. (JP) 2017-11-02 US disclosed
EP-3213739-A1 AGENT FOR IMPROVING MITOCHONDRIAL FUNCTION AND ANTI-AGING COMPOSITION Showa Denko K.K. (JP) 2017-09-06 EP disclosed
US-20150329754-A1 LIQUID COMPOSITION DAICEL CORPORATION (JP) 2015-11-19 US disclosed
US-7846970-B2 Hydroxycitric acid derivatives and skin external preparations containing the same SHOWA DENKO K.K. (JP) 2010-12-07 US disclosed
US-20080234224-A1 External Preparation For Skin SHOWA DENKO K.K. (JP) 2008-09-25 US disclosed
US-20070293577-A1 Hydroxycitric Acid Derivatives And Skin External Preparations Using The Same SHOWA DENKO K.K. (JP) 2007-12-20 US disclosed
US-20070232698-A1 Slimming Skin External Preparation and Cosmetic Containing the Same SHOWA DENKO K.K. (JP) 2007-10-04 US disclosed
US-20030157037-A1 Use of aryl oximes for the prophylaxis and/or treatment of erythema formation and/or inflammatory reaction of the skin MERCK PATENT GMBH (DE) 2003-08-21 US disclosed
US-5391564-A E.g., rhizoxin-13-yl 3-methylthiopropionate; anticarcinogenic agents SANKYO COMPANY, LIMITED (JP) 1995-02-21 US disclosed
US-5389626-A 3-aryloxmethyl-cephalosporin derivatives, and their medical use SANKYO COMPANY, LIMITED (JP) 1995-02-14 US disclosed
US-5352689-A Rhizoxin derivatives and their use as anti-tumor agents SANKYO COMPANY, LIMITED (JP) 1994-10-04 US disclosed
EP-0350315-B1 RHIZOXIN DERIVATES AND THEIR USE AS ANTI-TUMOR AGENTS SANKYO COMPANY LIMITED (JP) 1993-06-16 EP disclosed
EP-0363223-A2 3-Aryloxymethyl-cephalosporin derivatives, their preparation and their medical use Sankyo Company Limited (JP) 1990-04-11 EP disclosed
EP-0350315-A1 Rhizoxin derivates and their use as anti-tumor agents SANKYO COMPANY LIMITED (JP) 1990-01-10 EP disclosed
US-4288454-A Antiviral 1-adamantyl-3-(phenylsulfonyl)thioureas HOFFMAN-LA ROCHE INC. (US) 1981-09-08 US disclosed
US-4096145-A DYES FOR RESINS AND POLYESTER TEXTILES BASF AKTIENGESELLSCHAFT (DT) 1978-06-20 US disclosed
US-3950321-A POLYESTERS BASF AKTIENGESELLSCHAFT (DT) 1976-04-13 US disclosed